Get the Stockscreener App
316.42
0.09%
0.29
After Hours:
316.42
Overview
News
Price History
Option Chain
Financials
Why WST Down?
Discussions
Forecast
Stock Split
Dividend History
West Pharmaceutical Services Inc stock is traded at $316.42, with a volume of 533.75K.
It is up +0.09% in the last 24 hours and up +15.31% over the past month.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
See More
Previous Close:
$316.13
Open:
$314.62
24h Volume:
533.75K
Relative Volume:
0.61
Market Cap:
$22.35B
Revenue:
$3.22B
Net Income/Loss:
$542.70M
P/E Ratio:
42.30
EPS:
7.4805
Net Cash Flow:
$458.00M
1W Performance:
+4.47%
1M Performance:
+15.31%
6M Performance:
+16.73%
1Y Performance:
+51.77%
1-Day Range:
$311.07
$317.79
1-Week Range:
$299.72
$317.79
52-Week Range:
$203.74
$330.88
West Pharmaceutical Services Inc Stock (WST) Company Profile
Name
West Pharmaceutical Services Inc
Sector
Industry
Phone
(610) 594-2900
Address
530 HERMAN O. WEST DRIVE, EXTON, PA
Compare WST vs ISRG, BDX, ALC, MDLN, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
WST
West Pharmaceutical Services Inc
|
316.42 | 22.33B | 3.22B | 542.70M | 458.00M | 7.4805 |
ISRG
Intuitive Surgical Inc
|
438.10 | 155.76B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
147.63 | 40.30B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
67.78 | 33.13B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
37.01 | 31.37B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
208.05 | 30.31B | 5.54B | 1.52B | 1.74B | 10.37 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-02-25 | Initiated | Morgan Stanley | Equal-Weight |
| Sep-15-25 | Initiated | Rothschild & Co Redburn | Buy |
| Jun-24-25 | Initiated | Barclays | Equal Weight |
| Mar-18-25 | Initiated | Evercore ISI | Outperform |
| Feb-14-25 | Upgrade | Deutsche Bank | Hold → Buy |
| Jan-08-25 | Initiated | Citigroup | Buy |
| Dec-13-24 | Initiated | Wolfe Research | Peer Perform |
| Dec-12-24 | Upgrade | UBS | Neutral → Buy |
| Feb-07-24 | Upgrade | Jefferies | Hold → Buy |
| Jun-16-23 | Upgrade | BofA Securities | Neutral → Buy |
| Apr-11-23 | Upgrade | Stephens | Equal-Weight → Overweight |
| Dec-14-22 | Initiated | Deutsche Bank | Hold |
| Nov-30-22 | Initiated | UBS | Neutral |
| Oct-28-22 | Downgrade | BofA Securities | Buy → Neutral |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Oct-14-20 | Initiated | Stephens | Equal-Weight |
| Jul-21-20 | Upgrade | BofA Securities | Neutral → Buy |
| Apr-24-20 | Upgrade | BofA/Merrill | Underperform → Neutral |
| Dec-12-19 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jul-26-19 | Upgrade | BofA/Merrill | Underperform → Neutral |
| May-01-19 | Downgrade | Jefferies | Buy → Hold |
| Apr-23-19 | Initiated | William Blair | Outperform |
| Apr-25-18 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jan-24-18 | Initiated | Goldman | Neutral |
| Oct-17-17 | Downgrade | BofA/Merrill | Buy → Neutral |
| Oct-03-17 | Initiated | Stephens | Equal-Weight |
| Sep-15-17 | Upgrade | Jefferies | Hold → Buy |
| Oct-28-16 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Sep-21-16 | Downgrade | Wells Fargo | Outperform → Market Perform |
| Mar-22-16 | Initiated | Wells Fargo | Outperform |
| May-14-10 | Reiterated | UBS | Neutral |
| Feb-23-10 | Initiated | Jefferies & Co | Buy |
| Dec-19-08 | Initiated | UBS | Neutral |
View All
West Pharmaceutical Services Inc Stock (WST) Latest News
A Look At West Pharmaceutical Services (WST) Valuation After Recent Share Price Momentum - Yahoo Finance
WST Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Here's what to expect from West Pharmaceutical's next earnings report - MSN
West Pharma fully restores operations after cyber attack - MSN
West Pharmaceutical Services (NYSE:WST) Shows Explosive Potential with Perfect Minervini Trend Template and Accelerating Growth - ChartMill
West Pharmaceutical Services Gains Spotlight In S&P 500 Momentum - Kalkine Media
Q1 Earnings Recap: West Pharmaceutical Services (NYSE:WST) Tops Drug Development Inputs & Services Stocks - Yahoo Finance
Analysts Are Bullish on Top Healthcare Stocks: Belite Bio, Inc. ADR (BLTE), Centene (CNC) - The Globe and Mail
West Pharmaceutical restores operations after cyberattack - Plastics News
West Pharmaceutical Services (WST) Earnings Date and Reports 2026 $WST - MarketBeat
A Look at West Pharmaceutical Services Inc (WST) After 3.5% Gain -- GF Value $359.79 vs Price $316.13 - GuruFocus
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MarketWatch
West Pharmaceutical Shares Rise After Update on Restoration of Core Enterprise Systems Following Cyberattack - Moomoo
Here's Why You Should Retain OPK Stock in Your Portfolio for Now - TradingView
Reasons to Add West Pharmaceutical Stock to Your Portfolio Now - Zacks Investment Research
West Pharma says fully operational after cyberattack, sees no hit to 2026 forecast - WSAU
Cyber incident update: West Pharmaceutical (NYSE: WST) restores operations - Stock Titan
WST Stock Price, Quote & Chart | WEST PHARMACEUTICAL SERVICES (NYSE:WST) - ChartMill
Trump's Stock Picks Perfectly Timed With New Medicare Rules: ReportEli Lilly (NYSE:LLY) - Benzinga
West Pharma drops after cyber attack - MSN
Trump bought stock in drugmaker as his government boosted its obesity drugs - Fierce Pharma
S&P 500 gains and losses today: West Pharmaceutical Services stock surges; Dow, LKQ shares fall - MSN
West Declares Quarterly Dividend - Quantisnow
Ransomware Attacks on West Pharmaceutical and Foxconn Highlight Growing Cyber Risks to Manufacturing Sector - Homeland Security Today
Zacks Research Analysts Raise Earnings Estimates for WST - MarketBeat
West Pharmaceutical (WST) Provides Cyberattack Recovery Update - GuruFocus
West Pharmaceutical Services ramps production following cyberattack - Investing.com
West Pharmaceutical says making progress in restoring global operations after cyberattack - marketscreener.com
West Pharma says operations recovering after cyberattack - WSAU
West Pharmaceutical Services ramps production following cyberattack By Investing.com - Investing.com Canada
West Pharmaceutical Services Inc recently announced that the company has continued to make significant progress in restoring operations after responding to a global cyberattack incident. - Bitget
Apprenticeship Week highlights ‘earn-while-you-learn’ approach - The Pennsylvania State University
West Pharmaceutical Services Inc announced that its High Value Product (HVP) sites, standard packaging sites, and HVP delivery device sites have now fully resumed shipping and receiving operations. - Bitget
Here's Why You Should Add Pediatrix Medical to Your Portfolio Now - TradingView
DOCS Teams Up With Aledade to Bring Clinical AI to Value-Based Care - TradingView
Coated Butyl Rubber Stopper Market is Expanding Globally | Major - openPR.com
West Pharmaceutical Services (NYSE:WST) Upgraded to "Strong-Buy" at Zacks Research - MarketBeat
Cyberattack On West Pharmaceutical Halts Manufacturing Across Multiple Sites - Information Security Buzz
[Form 4] WEST PHARMACEUTICAL SERVICES INC Insider Trading Activity - Stock Titan
RVTY Expands Endocrine Diagnostics With FDA-Cleared Testosterone Assay - TradingView
Analysts Have Conflicting Sentiments on These Healthcare Companies: West Pharmaceutical Services (WST), CalciMedica (CALC) and Tyra Bioscience (TYRA) - The Globe and Mail
Doximity Stock Falls on Q4 Earnings Miss, Revenues Beat, Margins Down - TradingView
West Pharmaceutical starts restoring operations after ransomware attack - Cybersecurity Dive
Expert Insights on the West Pharmaceutical Ransomware Attack - Security Magazine
Reasons to Hold HealthEquity Stock in Your Portfolio for Now - TradingView
Ransomware attacks on West Pharmaceutical and Foxconn highlight growing cyber risks to manufacturing sector - Industrial Cyber
West Pharmaceutical stock (US9523901012): Ransomware attack disrupts operations - AD HOC NEWS
West Pharmaceutical Services (WST) Reports Material Cybersecurit - GuruFocus
West Pharmaceutical Services Inc (WST) Stock Price, Trades & News - GuruFocus
West Pharmaceutical says hackers stole data, encrypted systems - BleepingComputer
West Pharmaceutical Services Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
West Pharmaceutical Services Inc Stock (WST) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.45%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):